Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review
出版年份 2021 全文链接
标题
Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review
作者
关键词
-
出版物
Frontiers in Immunology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-03-10
DOI
10.3389/fimmu.2021.651687
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry
- (2019) Dong Wang et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Limitations and Off-Target Effects of Tryptophan-Related IDO Inhibitors in Cancer Treatment
- (2019) Juliane Günther et al. Frontiers in Immunology
- Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
- (2019) Georgina V Long et al. LANCET ONCOLOGY
- Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy
- (2018) Sarah Yentz et al. BIODRUGS
- Clinical and biological implications of mutational spectrum in acute myeloid leukemia of FAB subtypes M4 and M5
- (2018) Zhiheng Cheng et al. CANCER GENE THERAPY
- New and emerging therapies for acute myeloid leukaemia
- (2018) Julian R Davis et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells
- (2017) Varun Sasidharan Nair et al. IMMUNOLOGY AND CELL BIOLOGY
- Acute Myeloid Leukaemia: New Targets and Therapies
- (2017) Geoffrey Brown et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions
- (2017) Maria Larrosa-Garcia et al. MOLECULAR CANCER THERAPEUTICS
- ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells
- (2017) Mariangela Lecciso et al. Frontiers in Immunology
- A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expression
- (2017) Abhishek Mangaonkar et al. Scientific Reports
- Harnessing the immune system in acute myeloid leukaemia
- (2016) Rebecca Austin et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Indoleamine 2,3-dioxygenase and regulatory T cells in acute myeloid leukemia
- (2016) Iman Mansour et al. Hematology
- Prognostic value of the combination of seruml-kynurenine level and indoleamine 2,3-dioxygenase mRNA expression in acute myeloid leukemia
- (2016) Takeshi Hara et al. LEUKEMIA & LYMPHOMA
- TIM-3/Gal-9 interaction induces IFNγ-dependent IDO1 expression in acute myeloid leukemia blast cells
- (2015) Valentina Folgiero et al. Journal of Hematology & Oncology
- High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia
- (2015) Ryoko Mabuchi et al. LEUKEMIA & LYMPHOMA
- PGE2-Induced IDO1 Inhibits the Capacity of Fully Mature DCs to Elicit anIn VitroAntileukemic Immune Response
- (2015) Sara Trabanelli et al. Journal of Immunology Research
- Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia
- (2015) Valentina Folgiero et al. Oncotarget
- IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation
- (2014) Richard Metz et al. INTERNATIONAL IMMUNOLOGY
- Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics
- (2014) Kenji Fukuno et al. LEUKEMIA & LYMPHOMA
- Indoleamine 2,3 dioxygenase contributes to transferable tolerance in rat red blood cell inducible model of experimental autoimmune haemolytic anaemia
- (2013) L. N. Dahal et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
- (2013) Rikke B. Holmgaard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Acute myeloid leukaemia in adults
- (2013) Felicetto Ferrara et al. LANCET
- Cyclooxygenase-2 (COX-2) Inhibition Constrains Indoleamine 2,3-Dioxygenase 1 (IDO1) Activity in Acute Myeloid Leukaemia Cells
- (2013) Maria Iachininoto et al. MOLECULES
- Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion
- (2012) M. Platten et al. CANCER RESEARCH
- T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
- (2012) A. Facciabene et al. CANCER RESEARCH
- Indoleamine 2,3-dioxygenase: From catalyst to signaling function
- (2012) Francesca Fallarino et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CD4+CD25+CD127low/− T Cells: A More Specific Treg Population in Human Peripheral Blood
- (2012) Ning Yu et al. INFLAMMATION
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- FLT3 inhibition as a targeted therapy for acute myeloid leukemia
- (2010) Miguel Sanz et al. CURRENT OPINION IN ONCOLOGY
- Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells
- (2010) A. Curti et al. HAEMATOLOGICA
- Involvement of Oxidative Stress in the Relapse of Acute Myeloid Leukemia
- (2010) Fu-Ling Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells
- (2010) Noura M. El Kholy et al. MEDICAL ONCOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome
- (2008) M. E.D. Chamuleau et al. HAEMATOLOGICA
- Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients’ sera by HPLC and is inducible by IFN-γ
- (2008) Selim Corm et al. LEUKEMIA RESEARCH
- Toxicology and pharmacokinetics of 1-methyl-d-tryptophan: Absence of toxicity due to saturating absorption
- (2007) Lee Jia et al. FOOD AND CHEMICAL TOXICOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started